Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31068396 | 0.93 | ALDH1A1 (0.57) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| SCHEMBL28922554 | 0.93 | ALDH1A1 (0.57) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| SCHEMBL21436355 | 0.91 | MEN1 (0.46) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| SCHEMBL28200116 | 0.87 | MEN1 (0.47) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| SCHEMBL11073430 | 0.87 | MAPT (0.50) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| Hydrochloric Acid SCHEMBL8660554 | 0.85 | MEN1 (0.46) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| Hydrochloric Acid SCHEMBL8662102 | 0.85 | RAPGEF4 (0.48) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| SCHEMBL14586551 | 0.85 | MEN1 (0.46) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| SCHEMBL11581574 | 0.85 | MEN1 (0.48) | MEN1KMT2AALDH1A1KDM4EIDO1 | |
| Hydrochloric Acid SCHEMBL3642582 | 0.84 | MEN1 (0.44) | MEN1KMT2AALDH1A1KDM4EIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9455410-B2 | Micromolecular electron transport material based on pyridine and triazole, preparation method and organic light-emitting diode thereof | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2016-09-27 | — | — | US | disclosed |
| US-20150318485-A1 | MICROMOLECULAR ELECTRON TRANSPORT MATERIAL BASED ON PYRIDINE AND TRIAZOLE, PREPARATION METHOD AND ORGANIC LIGHT-EMITTING DIODE THEREOF | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2015-11-05 | — | — | US | disclosed |
| EP-2616071-A2 | FATTY ACID SYNTHASE INHIBITORS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2013-07-24 | — | — | EP | disclosed |
| US-20130172384-A1 | FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED | 2013-07-04 | — | — | US | disclosed |
| WO-2012037299-A2 | FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2012-03-22 | — | — | WO | disclosed |
| EP-0801649-A2 | HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE MOLECULAR CHAPERON PRODUCTION AND THE PREPARATION THEREOF | BIOREX KUTATO ES FEJLESZTÖ RT. (HU) | 1997-10-22 | — | — | EP | disclosed |
| US-5652239-A | TREATMENT OF STROKES, ISCHEMIC ATTACK, ANTAGONISTS OF EXCITATORY AMINO ACIDS GLUTAMATE AND ASPARTATE | IMPERIAL CHEMICAL COMPANY (GB) | 1997-07-29 | — | — | US | disclosed |
| WO-1997016439-A1 | HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE MOLECULAR CHAPERON PRODUCTION AND THE PREPARATION THEREOF | Biorex Kutató és Fejlesztó Rt. (HU) | 1997-05-09 | — | — | WO | disclosed |
| EP-0512817-B1 | Pyridazinedione derivatives, their preparation and pharmaceutical applications | ZENECA LTD (GB) | 1997-02-19 | — | — | EP | disclosed |
| EP-0512817-A1 | Pyridazinedione derivatives, their preparation and pharmaceutical applications | ZENECA LIMITED (GB) | 1992-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150318485-A1 | MICROMOLECULAR ELECTRON TRANSPORT MATERIAL BASED ON PYRIDINE AND TRIAZOLE, PREPARATION METHOD AND ORGANIC LIGHT-EMITTING DIODE THEREOF | TOMM34, MLNR, MAP1LC3B | MEN1 1282/4885KMT2A 4270/4885ALDH1A1 1200/4885 |
| US-20130172384-A1 | FATTY ACID SYNTHASE INHIBITORS | FASN, FADS1, FADS2 | MEN1 4467/4885KMT2A 2500/4885ALDH1A1 671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.